Physician profile
Michael Sawyer
NPI 1336148667
$510,841.53
in general payments reported to CMS, 2019-2025
18 companies · $17K in 2025
The $17K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93K · 2020: $41K · 2021: $95K · 2022: $137K · 2023: $83K · 2024: $45K · 2025: $17K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $114K · Travel and Lodging: $15K · Food and Beverage: $8,015 · Education: $8,000 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $113,950.00 |
| Travel and Lodging | $14,963.59 |
| Food and Beverage | $8,014.86 |
| Education | $8,000.00 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $483,176.11 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Tas Medical, INC. | $15,775.34 | 2024 | |
| Intuitive Surgical, INC. | $10,563.67 | 2021-2024 | |
| Origami Surgical INC | $500.00 | 2025 | Stitchkit |
| Conmed Corporation | $263.30 | 2021-2025 | Airseal, Visiclear, Conmed Specimen Retrieval |
| Ethicon US, LLC | $122.36 | 2019 | |
| Abbvie INC. | $115.31 | 2023-2025 | Rinvoq, Skyrizi |
| Davol INC. | $80.92 | 2023-2024 | Phasix Mesh |
| Medtronic, INC. | $50.99 | 2025 | Transorb |
| Sirius Medical Systems | $43.42 | 2024 | Pintuition |
| Teleflex LLC | $39.15 | 2023 | Titan Sgs Standard Gastric Stapler |
| Pacira Pharmaceuticals Incorporated | $19.93 | 2019 | |
| Novo Nordisk INC | $16.79 | 2025 | Wegovy |
| Vertex Pharmaceuticals Incorporated | $16.73 | 2024 | |
| Ambu INC. | $16.63 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $16.09 | 2025 | Voquezna |
| Janssen Biotech, INC. | $13.79 | 2023 | Stelara |
| Endo Pharmaceuticals INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sawyer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.